Evidence map›Paper›PMID 41131344›Full record

ArticleNPJ digital medicine2025

Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets.

Tjardo D Maarseveen, Marc P Maurits, Lavinia Agra Coletto, Simone Perniola, Stefan Böhringer, Nils Steinz, Sytske Anne Bergstra, Dario Bruno, Maria Rita Gigante, Viviana A Pacucci and 16 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Tjardo D MaarseveenDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Marc P MauritsDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Lavinia Agra ColettoDivision of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Simone PerniolaDivision of Clinical Immunology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Stefan BöhringerDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands.
Nils SteinzDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Sytske Anne BergstraDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Dario BrunoDivision of Clinical Immunology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Maria Rita GiganteDivision of Clinical Immunology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Viviana A PacucciDivision of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Luca PetriccaDivision of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Bianca Boxma-de KlerkDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Herman Kasper GlasRheumatology outpatient clinics, Reumazorg Zuid West Nederland, Goes, Netherlands.
Clara Di MarioImmunology Research Core Facility - Gemelli Science and Technology Park (GSTeP) - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Denise CampobassoImmunology Research Core Facility - Gemelli Science and Technology Park (GSTeP) - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Barbara TolussoImmunology Research Core Facility - Gemelli Science and Technology Park (GSTeP) - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Josien Veris-van DierenRheumatology outpatient clinics, Reumazorg Zuid West Nederland, Goes, Netherlands.
Annette H M van der Helm-van MilDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Elisa GremeseDivision of Clinical Immunology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Maria Antonietta D'AgostinoDivision of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Marcel J T ReindersLeiden Computational Biology Centre, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands.
Marco GessiInstitute of Pathology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Tom W J HuizingaDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.
Stefano AliverniniDivision of Rheumatology - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Erik B van den AkkerLeiden Computational Biology Centre, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands.
Rachel KnevelDepartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands. r.knevel@lumc.nl.

Funding

HORIZON EUROPE European Research Council 101071386HORIZON EUROPE Health 101080711HORIZON EUROPE Health 101095052ZonMw 09120012110075
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a heterogeneous disease with variable symptoms, prognosis, and treatment response, necessitating refined patient classification. We applied multimodal deep learning and clustering to identify distinct RA phenotypes using baseline clinical data from 1,387 patients in the Leiden Rheumatology clinic. Four Joint Involvement Patterns (JIP) emerged: foot-predominant arthritis, seropositive oligoarticular disease, seronegative hand arthritis, and polyarthritis. Findings were validated in clinical trial data (n = 307) and an independent secondary care cohort (n = 515). Clusters showed high stability and significant differences in remission rates (P = 0.007) and methotrexate failure (P < 0.001). JIP-hand patients had superior outcomes (particularly in ACPA-positive patients) versus JIP-foot (HR:0.37, P < 0.001) and JIP-poly (HR:0.33, P = 0.005), independent of baseline disease activity and clinical markers. Synovial histology analysis (n = 194) revealed distinct inflammatory patterns across clusters, hinting at different underlying biological mechanisms. These validated RA phenotypes based on joint involvement patterns may enable targeted research into disease mechanisms and personalized treatment strategies.

Identifiers

PMID41131344
PMCPMC12550013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.